Global Blood Screening Market Analysis, 2020

Rising Infectious Diseases Projected to Spur the Global Blood Screening Market Growth

Blood screening is a medical process that detects markers of infection in order to prevent the release of infected blood and blood components for clinical use. This technology is widely used in various fields of diagnostics of diseases such as HIV, cancer, and infectious diseases.

Global Blood Screening Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Blood Screening market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end-users, applications, product type, technologies, competitive benchmarking, etc.

According to this research report titled “Global Blood Screening Market Analysis, 2020”, the Global Blood Screening market is anticipated to grow at a CAGR of around 8.5% during 2020-25F on an account of a boost in the geriatric population and surging number of trauma cases. In addition, growing technological advancement in blood screening, burgeoning government healthcare expenditure in infrastructural development of hospitals in the emerging economies such as India and China, and proliferating demand for blood screening tests due to rising blood donations by the people are key factors which are projected to lead to a considerable impact toward the growth of Global Blood Screening market in the forecast years.

Blood Bank Dominated the Global Screening Market

Based on end user, blood banks dominated the market and is projected to continue its dominance by 2025 owing to rising awareness and participation of the public in blood donation. Besides this, increasing awareness regarding the safety of blood, rising government funding to charitable trusts along with a significant rise in the organ transplantation surgeries and road accidents across the globe is anticipated to strongly contribute toward the growth of the Blood Screening market globally in the near future as stated in the research report “Global Blood Screening Market Analysis, 2020”.

.

According to the publisher, the key players with a considerable market share in the Global Blood Screening market include Grifols, Abbott, Roche, Bio-Rad, Biomerieux, Thermo Fisher, Diasorin, Perkinelmer etc.

Key Questions Answered in the Market Research Report:

1. What are the key overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of Global Blood Screening Market?
2. What is the region wise industry size, growth drivers and challenges key market trends?
3. What are the key innovations, technology upgrades, opportunities, regulations in the Global Blood Screening Market?
4. Who are the key competitors or market players and how they perform in Global Blood Screening Market based on competitive benchmarking matrix?
5. What are the key results derived from the market surveys conducted during the course of Global Blood Screening Market study?

1. Introduction

1.1. Product Definition
1.2. Research Process
1.3. Market Segmentation
1.4. Assumptions

2. Executive Summary3. Global Healthcare Market Overview4. Impact of COVID-19 on Global Blood Screening Market5. Expert Verbatim-Interview Excerpts of industry experts

6. Global Blood Screening Market Outlook, 2015-2025

6.1. Market Size & Analysis
6.1.1. Revenues
6.2. Market Share & Analysis
6.2.1. By Solutions
6.2.1.1. Reagents & Kits
6.2.1.1.1. Nucleic Acid Technology (NAT)
6.2.1.1.1.1. Enzymes & Polymerases
6.2.1.1.1.2. Standards & Controls
6.2.1.1.1.3. Probes & Primers
6.2.1.1.1.4. Buffers, Nucleotides, And Solutions
6.2.1.1.1.5. Labeling & Detection Reagents
6.2.1.1.2. Elisa
6.2.1.1.2.1. Immunosorbents
6.2.1.1.2.2. Controls
6.2.1.1.2.3. Conjugates
6.2.1.1.2.4. Substrates
6.2.1.1.2.5. Sample Diluents & Wash Solutions
6.2.1.2. Instruments
6.2.1.2.1. Rental Purchase
6.2.1.2.2. Outright Purchase
6.2.1.3. Software & Services
6.2.2. By Technology
6.2.2.1. Nucleic Acid Testing
6.2.2.1.1. Transcription-Mediated Amplification
6.2.2.1.2. Real-Time Polymerase Chain Reaction
6.2.2.2. Enzyme-Linked Immunosorbent Assay
6.2.2.2.1. Chemiluminescence Immunoassay
6.2.2.2.2. Fluorescent Immunoassay
6.2.2.2.3. Colorimetric Immunoassays
6.2.2.3. Rapid Tests
6.2.2.4. Western Blot Assays
6.2.2.5. Next-Generation Sequencing (NGS)
6.2.3. By End User
6.2.3.1. Blood Banks
6.2.3.2. Hospitals
6.2.4. By Region
6.2.4.1. North America
6.2.4.2. South America
6.2.4.3. Europe
6.2.4.4. Middle East & Africa
6.2.4.5. Asia-Pacific
6.2.5. By Company
6.2.5.1. Market Shares, By Revenue
6.2.5.2. Strategic Factorial Indexing
6.2.5.3. Competitor Placement in MarkNtel Quadrant
6.3. Market Attractiveness Index
6.3.1. By Solutions
6.3.2. By Technology
6.3.3. By End User
6.3.4. By Region

7. North America Blood Screening Market Outlook, 2015-2025

7.1. Market Size & Analysis
7.1.1. Revenues
7.2. Market Share & Analysis
7.2.1. By Solutions
7.2.2. By Technology
7.2.3. By End User
7.2.4. By Country
7.2.4.1. The US
7.2.4.2. Canada
7.2.4.3. Mexico
7.3. The US Blood Screening Market Outlook, 2015-2025
7.3.1. Market Size & Analysis
7.3.1.1. Revenues
7.3.2. Market Share & Analysis
7.3.2.1. By Solutions
7.3.2.2. By Technology
7.3.2.3. By End User
7.4. Canada Blood Screening Market Outlook, 2015-2025
7.4.1. Market Size & Analysis
7.4.1.1. Revenues
7.4.2. Market Share & Analysis
7.4.2.1. By Solutions
7.4.2.2. By Technology
7.4.2.3. By End User
7.5. Mexico Blood Screening Market Outlook, 2015-2025
7.5.1. Market Size & Analysis
7.5.1.1. Revenues
7.5.2. Market Share & Analysis
7.5.2.1. By Solutions
7.5.2.2. By Technology
7.5.2.3. By End User

8. South America Blood Screening Market Outlook, 2015-2025

8.1. Market Size & Analysis
8.1.1. Revenues
8.2. Market Share & Analysis
8.2.1. By Solutions
8.2.2. By Technology
8.2.3. By End User
8.2.4. By Country
8.2.4.1. Brazil
8.2.4.2. Others
8.3. Brazil Blood Screening Market Outlook, 2015-2025
8.3.1. Market Size & Analysis
8.3.1.1. Revenues
8.3.2. Market Share & Analysis
8.3.2.1. By Solutions
8.3.2.2. By Technology
8.3.2.3. By End User

9. Europe Blood Screening Market Outlook, 2015-2025

9.1. Market Size & Analysis
9.1.1. Revenues
9.2. Market Share & Analysis
9.2.1. By Solutions
9.2.2. By Technology
9.2.3. By End User
9.2.4. By Country
9.2.4.1. Germany
9.2.4.2. The UK
9.2.4.3. France
9.2.4.4. Italy
9.2.4.5. Spain
9.2.4.6. Others
9.3. Germany Blood Screening Market Outlook, 2015-2025
9.3.1. Market Size & Analysis
9.3.1.1. Revenues
9.3.2. Market Share & Analysis
9.3.2.1. By Solutions
9.3.2.2. By Technology
9.3.2.3. By End User
9.4. The UK Blood Screening Market Outlook, 2015-2025
9.4.1. Market Size & Analysis
9.4.1.1. Revenues
9.4.2. Market Share & Analysis
9.4.2.1. By Solutions
9.4.2.2. By Technology
9.4.2.3. By End User
9.5. France Blood Screening Market Outlook, 2015-2025
9.5.1. Market Size & Analysis
9.5.1.1. Revenues
9.5.2. Market Share & Analysis
9.5.2.1. By Solutions
9.5.2.2. By Technology
9.5.2.3. By End User
9.6. Italy Blood Screening Market Outlook, 2015-2025
9.6.1. Market Size & Analysis
9.6.1.1. Revenues
9.6.2. Market Share & Analysis
9.6.2.1. By Solutions
9.6.2.2. By Technology
9.6.2.3. By End User
9.7. Spain Blood Screening Market Outlook, 2015-2025
9.7.1. Market Size & Analysis
9.7.1.1. Revenues
9.7.2. Market Share & Analysis
9.7.2.1. By Solutions
9.7.2.2. By Technology
9.7.2.3. By End User

10. Middle East & Africa Blood Screening Market Outlook, 2015-2025

10.1. Market Size & Analysis
10.1.1. Revenues
10.2. Market Share & Analysis
10.2.1. By Solutions
10.2.2. By Technology
10.2.3. By End User
10.2.4. By Country
10.2.4.1. UAE
10.2.4.2. Saudi Arabia
10.2.4.3. South Africa
10.2.4.4. Others
10.3. UAE Blood Screening Market Outlook, 2015-2025
10.3.1. Market Size & Analysis
10.3.1.1. Revenues
10.3.2. Market Share & Analysis
10.3.2.1. By Solutions
10.3.2.2. By Technology
10.3.2.3. By End User
10.4. Saudi Arabia Blood Screening Market Outlook, 2015-2025
10.4.1. Market Size & Analysis
10.4.1.1. Revenues
10.4.2. Market Share & Analysis
10.4.2.1. By Solutions
10.4.2.2. By Technology
10.4.2.3. By End User
10.5. South Africa Blood Screening Market Outlook, 2015-2025
10.5.1. Market Size & Analysis
10.5.1.1. Revenues
10.5.2. Market Share & Analysis
10.5.2.1. By Solutions
10.5.2.2. By Technology
10.5.2.3. By End User

11. Asia-Pacific Blood Screening Market Outlook, 2015-2025

11.1. Market Size & Analysis
11.1.1. Revenues
11.2. Market Share & Analysis
11.2.1. By Solutions
11.2.2. By Technology
11.2.3. By End User
11.2.4. By Country
11.2.4.1. China
11.2.4.2. India
11.2.4.3. Japan
11.2.4.4. Australia
11.2.4.5. Others
11.3. China Blood Screening Market Outlook, 2015-2025
11.3.1. Market Size & Analysis
11.3.1.1. Revenues
11.3.2. Market Share & Analysis
11.3.2.1. By Solutions
11.3.2.2. By Technology
11.3.2.3. By End User
11.4. India Blood Screening Market Outlook, 2015-2025
11.4.1. Market Size & Analysis
11.4.1.1. Revenues
11.4.2. Market Share & Analysis
11.4.2.1. By Solutions
11.4.2.2. By Technology
11.4.2.3. By End User
11.5. Japan Blood Screening Market Outlook, 2015-2025
11.5.1. Market Size & Analysis
11.5.1.1. Revenues
11.5.2. Market Share & Analysis
11.5.2.1. By Solutions
11.5.2.2. By Technology
11.5.2.3. By End User
11.6. Australia Blood Screening Market Outlook, 2015-2025
11.6.1. Market Size & Analysis
11.6.1.1. Revenues
11.6.2. Market Share & Analysis
11.6.2.1. By Solutions
11.6.2.2. By Technology
11.6.2.3. By End User

12. Global Blood Screening Market Policies, Regulations, Product Standards13. Global Blood Screening Market Trends & Insights

14. Global Blood Screening Market Dynamics

14.1. Growth Drivers
14.2. Challenges
14.3. Impact Analysis

15. Global Blood Screening Market Hotspot & Opportunities16. Global Blood Screening Market Key Strategic Imperatives for Success & Growth

17. Competition Outlook

17.1. Competition Matrix
17.1.1. Product Portfolio
17.1.2. Target Markets
17.1.3. Target End Users
17.1.4. Research & Development
17.1.5. Strategic Alliances
17.1.6. Strategic Initiatives
17.2. Company Profiles of top companies (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
17.2.1. Grifols
17.2.2. Abbott
17.2.3. Roche
17.2.4. Bio-Rad
17.2.5. Biomerieux
17.2.6. Thermo Fisher
17.2.7. Diasorin
17.2.8. Perkinelmer

18. Disclaimer